MIRADOR

Serial Number 98262764
730

Registration Progress

Application Filed
Nov 9, 2023
Under Examination
Nov 26, 2024
Approved for Publication
Oct 1, 2024
Published for Opposition
Oct 1, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Nov 26, 2025 130 days

Trademark Image

MIRADOR

Basic Information

Serial Number
98262764
Filing Date
November 9, 2023
Published for Opposition
October 1, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Apr 30, 2025
Application
Pending
Classes
001

Rights Holder

Mirador Therapeutics, Inc.

03
Address
3115 Merryfield Row, Suite 210
San Diego, CA 92121

Ownership History

Mirador Therapeutics, Inc.

Original Applicant
03
San Diego, CA

Mirador Therapeutics, Inc.

Owner at Publication
03
San Diego, CA

Legal Representation

Attorney
Brent D. Sokol

USPTO Deadlines

Next Deadline
130 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
November 26, 2025
Extension Available
Until November 26, 2025

Application History

30 events
Date Code Type Description Documents
Apr 30, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 30, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 29, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 29, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 26, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 1, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 1, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 11, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 24, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 24, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 24, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Aug 24, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 24, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 14, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 14, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 14, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 18, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 18, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 18, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 17, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 15, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 15, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 15, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 15, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 15, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 11, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 11, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 11, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Dec 11, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 13, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Chemical substances, chemical materials and chemical preparations for scientific purposes; Active pharmaceutical ingredients, namely, antibodies, proteins and small molecules for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products for the diagnosis, prevention, or treatment of inflammation and immunology disorders or diseases, autoimmune diseases, cancer, and other diseases of the immune systems, digestive systems, skin, joint, lung, liver, kidney, bile duct, nervous systems, or gastrointestinal systems; Antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines

Additional Information

Translation
The English translation of "MIRADOR" in the mark is "vantage point".

Classification

International Classes
001